12-45891802-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_152641.4(ARID2):​c.4945G>C​(p.Val1649Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000665 in 1,614,112 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00047 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00069 ( 9 hom. )

Consequence

ARID2
NM_152641.4 missense

Scores

3
6
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2O:1

Conservation

PhyloP100: 9.32

Publications

9 publications found
Variant links:
Genes affected
ARID2 (HGNC:18037): (AT-rich interaction domain 2) This gene encodes a member of the AT-rich interactive domain (ARID)-containing family of DNA-binding proteins. Members of the ARID family have roles in embryonic patterning, cell lineage gene regulation, cell cycle control, transcriptional regulation and chromatin structure modification. This protein functions as a subunit of the polybromo- and BRG1-associated factor or PBAF (SWI/SNF-B) chromatin remodeling complex which facilitates ligand-dependent transcriptional activation by nuclear receptors. Mutations in this gene are associated with hepatocellular carcinomas. A pseudogene of this gene is found on chromosome1. [provided by RefSeq, Dec 2016]
ARID2 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Illumina, Orphanet, ClinGen
  • Coffin-Siris syndrome 6
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012111098).
BP6
Variant 12-45891802-G-C is Benign according to our data. Variant chr12-45891802-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 133572.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000473 (72/152264) while in subpopulation SAS AF = 0.00477 (23/4820). AF 95% confidence interval is 0.00326. There are 0 homozygotes in GnomAd4. There are 45 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 72 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARID2NM_152641.4 linkc.4945G>C p.Val1649Leu missense_variant Exon 17 of 21 ENST00000334344.11 NP_689854.2
ARID2NM_001347839.2 linkc.4945G>C p.Val1649Leu missense_variant Exon 17 of 20 NP_001334768.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARID2ENST00000334344.11 linkc.4945G>C p.Val1649Leu missense_variant Exon 17 of 21 1 NM_152641.4 ENSP00000335044.6

Frequencies

GnomAD3 genomes
AF:
0.000473
AC:
72
AN:
152146
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00477
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000456
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00109
AC:
275
AN:
251254
AF XY:
0.00140
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000521
Gnomad ASJ exome
AF:
0.000893
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000828
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000685
AC:
1002
AN:
1461848
Hom.:
9
Cov.:
31
AF XY:
0.000865
AC XY:
629
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33480
American (AMR)
AF:
0.000559
AC:
25
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000651
AC:
17
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.00499
AC:
430
AN:
86258
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53414
Middle Eastern (MID)
AF:
0.00468
AC:
27
AN:
5768
European-Non Finnish (NFE)
AF:
0.000404
AC:
449
AN:
1111988
Other (OTH)
AF:
0.000778
AC:
47
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
61
122
183
244
305
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000473
AC:
72
AN:
152264
Hom.:
0
Cov.:
32
AF XY:
0.000604
AC XY:
45
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.000169
AC:
7
AN:
41540
American (AMR)
AF:
0.000458
AC:
7
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00477
AC:
23
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000456
AC:
31
AN:
68024
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000812
Hom.:
1
Bravo
AF:
0.000400
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00134
AC:
163
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.00125
EpiControl
AF:
0.00148

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ARID2: BS2

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.93
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Uncertain
0.020
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.039
T;T;.;.
Eigen
Uncertain
0.19
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.89
D;.;D;D
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.012
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.0
L;.;.;.
PhyloP100
9.3
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
-0.97
N;N;N;N
REVEL
Benign
0.22
Sift
Benign
0.10
T;T;T;T
Sift4G
Uncertain
0.051
T;T;T;D
Vest4
0.74
ClinPred
0.054
T
GERP RS
5.2
PromoterAI
0.015
Neutral
Varity_R
0.32
gMVP
0.49
Mutation Taster
=68/32
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201268655; hg19: chr12-46285585; COSMIC: COSV57606957; API